Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

ClinicalTrials.gov ID: NCT01770145

Public ClinicalTrials.gov record NCT01770145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Open-Label, Efficacy and Safety Study of Apokyn® for Rapid and Reliable Improvement of Motor Symptoms in Parkinson Disease Subjects With Delayed Onset of L-Dopa Action

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action.

Study identification

NCT ID
NCT01770145
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
127 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2012 (Type not available)
Primary completion
Apr 2014 (Actual)
Completion
Apr 2014 (Actual)
Last update posted
Aug 14, 2023

2012 – 2014

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Keck School of Medicine Los Angeles California 90033 —
Neurosearch, Inc. Reseda California 91335 —
Georgetown University Washington D.C. District of Columbia 20007 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Rush University Medical Center Chicago Illinois 60612 —
Henry Ford West Bloomfield Hospital Bloomfield Hills Michigan 48322 —
Parkinson's Disease and Movement Disorders Center of New York Commack New York 11725 —
University of Cincinnati Academic Health Center Cincinnati Ohio 45267 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136 —
University of Texas Health Science Center, Houston, Department of Neurology Houston Texas 77030 —
Center for Neurological Care and Research San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01770145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2023 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01770145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →